At a glance
ClinicalIndex Comparison RecordN/ACompleted· 419 enrolled
Drug / intervention
Triathlon® CR Total Knee Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-market, Non-randomized, Historical Controlled, Multi-center Study of the Outcomes of the Triathlon® Cruciate Retaining (CR) Total Knee System
In Brief
A clinical study evaluating Triathlon® CR Total Knee System for Arthroplasty, Replacement, Knee. Completed, enrolled 419 participants across 11 sites.
Detailed Summary
The purpose of this study is to evaluate the clinical outcomes (range of motion, pain, function, radiographic stability, and health related quality of life) of patients receiving the Triathlon® Cruciate Retaining (CR) Total Knee System. These outcomes will be evaluated by comparing pre-operative to post-operative scores, as well as to a control group. The control group is the Scorpio® CR Total Knee System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasty, Replacement, Knee
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2005
First PostedAug 2009
Primary CompletionApr 2010
Study CompletionSep 2017
TodayJul 2026
First PostedAug 12, 2009
Enrollment StartFeb 1, 2005
Primary CompletionApr 1, 2010
Study CompletionSep 26, 2017
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 16.9 years ago
Interventions
Triathlon® CR Total Knee Systemdevice
The purpose is to evaluate the Triathlon® CR Total Knee System.